Novo Nordisk Foundation commits up to $260 M to establish research and vaccine development initiative

Denmark-based Novo Nordisk Foundation is committing up to DKK 1.8 billion ($260 million) to establish a state-...

December 18, 2023 | Monday | News
CEPI supports novel mRNA vaccine development in Korea to protect against future Disease X

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has partnered with Korea’s Chungbuk National U...

December 12, 2023 | Tuesday | News
DxVx plans clinical trials of cancer vaccine in Asia, including Korea and China

South Korea-based DxVx will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix (OVM...

November 27, 2023 | Monday | News
Chulalongkorn University in Thailand supports UK-South East Asia vaccine manufacturing research hub

Thailand's Chulalongkorn University and the University of Sheffield, England, have signed an academic cooperation agreem...

November 24, 2023 | Friday | News
Korea accelerates innovations in vaccines and immunology

The International Vaccine Institute (IVI) and the Korea Advanced Institute of Science and Technology (KAIST) have signed...

November 23, 2023 | Thursday | News
SK bioscience and Hilleman Laboratories to develop Zaire Ebola Virus vaccine

South Korea-based SK bioscience has entered into a development licensing agreement with Hilleman Laboratories, in Singap...

November 22, 2023 | Wednesday | News
Hong Kong Jockey Club Global Health Institute to bolster global preparedness for future pandemics

The University of Hong Kong (HKU), the University of Cambridge (UCAM), and the International Vaccine Institute (IVI) hav...

November 17, 2023 | Friday | News
New typhoid conjugate vaccine Bio-TCV receives approval in Indonesia

South Korea-based International Vaccine Institute (IVI) and Bio Farma, a biotechnology company based in West Java, Indon...

November 14, 2023 | Tuesday | News
US FDA approves first chikungunya vaccine Ixchiq developed by Austria's Valneva

The US Food and Drug Administration (FDA) has approved Ixchiq, the first chikungunya vaccine, developed by Valneva ...

November 10, 2023 | Friday | News
Hilleman Lab invest $20M to launch new ACES cGMP Facility in Singapore

On 9 November, Hilleman Laboratories opened its ACES current Good Manufacturing Practices (cGMP) facility in Singapore w...

November 9, 2023 | Thursday | Company results
UK injects £33 M to develop vaccines for diseases with epidemic potential in LMICs

Four vaccine hubs have received a share of £33 million of UK aid funding via the Department of Health and Soc...

November 9, 2023 | Thursday | News
The Netherlands bolsters pandemic preparedness with increased funding

The Netherlands Ministry of Health, Sports and Welfare has announced an additional EUR 14 million contribution to Norway...

November 7, 2023 | Tuesday | News
Korea's SK Bioscience to boost vaccine manufacturing in Africa

South Korea-based SK bioscience recently announced that Dr Jean Kaseya, Director General, African Centers...

November 6, 2023 | Monday | News
Korea organises training programme for African vaccine manufacturing players

South Korea-based International Vaccine Institute (IVI) has partnered with KEMRI-Wellcome Trust Research Programme (KWTR...

November 1, 2023 | Wednesday | News
CEPI to harness Moderna’s mRNA platform for vaccine development against viral disease outbreaks

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and American firm Moderna, Inc. have entered into ...

October 30, 2023 | Monday | News
World-first trial by Australia to test efficacy of Strep A and rheumatic heart disease vaccine

Australia-based Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation fro...

October 25, 2023 | Wednesday | News
Reinforcing healthcare equity, access, and resilience by fine-tuning the pharma supply chain in ASEAN market

As the world is progressively rebounding from pandemic impact, Moderna is constantly developing next-generation combinat...

October 19, 2023 | Thursday | Opinion
Australia’s Doherty Institute joins CEPI to speed up pandemic vaccines development

The Peter Doherty Institute for Infection and Immunity, a joint venture between the University of Melbourne and the Roya...

October 20, 2023 | Friday | News